OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

FOSUN INTL LTD/  HK0656038673  /

Frankfurt
31/05/2024  09:03:35 Chg. 0.0000 Volume Bid17:16:15 Ask17:16:15 Market Capitalization Dividend Y. P/E Ratio
0.5300EUR 0.00% 6,000
Turnover: 3,180		 -Bid Size: - -Ask Size: - 4.76 bill.EUR - -
GlobeNewswire 30/05 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 29/05 BioNTech and CEPI Expand Partnership to Strengthen Africa’s mRNA Vaccine Ecosystem
GlobeNewswire 22/05 Ardelyx to Participate at the 2024 Jefferies Global Healthcare Conference
GlobeNewswire 21/05 Ardelyx Presents Additional Data at the 2024 Digestive Disease Week Conference on IBSRELA® (tenapano...
GlobeNewswire 21/05 BioNTech to Present Clinical Data Updates for Next-Generation Immunotherapy Candidates at the ASCO A...
GlobeNewswire 17/05 BioNTech SE Shareholders Approve All Agenda Items at the Annual General Meeting 2024
GlobeNewswire 16/05 Ardelyx Presents Additional Data at the NKF 2024 Spring Clinical Meetings on XPHOZAH® (tenapanor)
GlobeNewswire 14/05 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 07/05 Nature’s Sunshine Reports Strong First Quarter 2024 Results
GlobeNewswire 07/05 Ardelyx to Present Additional Data Supporting First-In-Class IBSRELA® (tenapanor) for Adults with Ir...
GlobeNewswire 06/05 BioNTech Announces First Quarter 2024 Financial Results and Corporate Update
GlobeNewswire 02/05 Ardelyx Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 01/05 Ardelyx to Present Additional Data Supporting First-In-Class XPHOZAH® (tenapanor) for Adults with Ch...
GlobeNewswire 22/04 BioNTech to Report First Quarter 2024 Financial Results and Corporate Update on May 6, 2024
GlobeNewswire 18/04 Intuitive Announces First Quarter Earnings
GlobeNewswire 18/04 Ardelyx to Report First Quarter 2024 Financial Results on May 2, 2024
GlobeNewswire 07/04 Three-year Phase 1 Follow-Up Data for mRNA-based Individualized Immunotherapy Candidate Show Persis...
GlobeNewswire 28/03 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 25/03 Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate ...
GlobeNewswire 20/03 BioNTech Announces Fourth Quarter and Full Year 2023 Financial Results and Corporate Update
GlobeNewswire 20/03 BioNTech Announces Appointment of Annemarie Hanekamp to Management Board as Chief Commercial Officer
GlobeNewswire 12/03 Ardelyx, Inc. Reports Employment Inducement Grants
GlobeNewswire 12/03 Nature's Sunshine Reports Strong Fourth Quarter and Full Year 2023 Financial Results
GlobeNewswire 11/03 BioNTech to Present Clinical Data Updates for Personalized mRNA-based and Targeted Oncology Candidat...
GlobeNewswire 07/03 BioNTech Announces Planned Retirement of Sean Marett